Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Kimball

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|May 1, 1988
Studies directed toward ascertaining the active conformation of 1,4-dihydropyridine calcium entry blockersG Rovnyak, N Andersen, J Gougoutas, et al.
British Journal of Pharmacology|May 24, 2000
High affinity interaction of mibefradil with voltage-gated calcium and sodium channelsP Eller, S Berjukov, S Wanner, et al.
Journal of Medicinal Chemistry|August 21, 1992
Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agentsG C Rovnyak, K S Atwal, A Hedberg, et al.
Biochemistry|March 14, 1995
Benzothiazepine binding domain of purified L-type calcium channels: direct labeling using a novel fluorescent diltiazem analogueT Brauns, Z W Cai, S D Kimball, et al.
Journal of Medicinal Chemistry|January 6, 1995
Calcium entry blockers and activators: conformational and structural determinants of dihydropyrimidine calcium channel modulatorsG C Rovnyak, S D Kimball, B Beyer, et al.
Journal of Medicinal Chemistry|February 21, 1992
Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding siteS D Kimball, D M Floyd, J Das, et al.
Journal of Medicinal Chemistry|July 10, 1992
Benzazepinone calcium channel blockers. 5. Effects on antihypertensive activity associated with N1 and aromatic substituentsJ Das, D M Floyd, S D Kimball, et al.
Bioorganic & Medicinal Chemistry|October 1, 1993
1-Benzazepin-2-one calcium channel blockers--VI. Receptor-binding model and possible relationship to desmethoxyverapamilS D Kimball, J T Hunt, J C Barrish, et al.
Journal of Medicinal Chemistry|September 1, 1990
Dihydropyrimidine calcium channel blockers. 2. 3-substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridinesK S Atwal, G C Rovnyak, S D Kimball, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 10, 2003
Oxidative activation of acylguanidine prodrugs: intestinal presystemic activation in rats limits absorption and can be inhibited by co-administration of ketoconazoleW G Humphreys, M T Obermeier, S Chong, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|May 1, 1988
Studies directed toward ascertaining the active conformation of 1,4-dihydropyridine calcium entry blockersG Rovnyak, N Andersen, J Gougoutas, et al.
British Journal of Pharmacology|May 24, 2000
High affinity interaction of mibefradil with voltage-gated calcium and sodium channelsP Eller, S Berjukov, S Wanner, et al.
Journal of Medicinal Chemistry|August 21, 1992
Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agentsG C Rovnyak, K S Atwal, A Hedberg, et al.
Biochemistry|March 14, 1995
Benzothiazepine binding domain of purified L-type calcium channels: direct labeling using a novel fluorescent diltiazem analogueT Brauns, Z W Cai, S D Kimball, et al.
Journal of Medicinal Chemistry|January 6, 1995
Calcium entry blockers and activators: conformational and structural determinants of dihydropyrimidine calcium channel modulatorsG C Rovnyak, S D Kimball, B Beyer, et al.
Journal of Medicinal Chemistry|February 21, 1992
Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding siteS D Kimball, D M Floyd, J Das, et al.
Journal of Medicinal Chemistry|July 10, 1992
Benzazepinone calcium channel blockers. 5. Effects on antihypertensive activity associated with N1 and aromatic substituentsJ Das, D M Floyd, S D Kimball, et al.
Bioorganic & Medicinal Chemistry|October 1, 1993
1-Benzazepin-2-one calcium channel blockers--VI. Receptor-binding model and possible relationship to desmethoxyverapamilS D Kimball, J T Hunt, J C Barrish, et al.
Journal of Medicinal Chemistry|September 1, 1990
Dihydropyrimidine calcium channel blockers. 2. 3-substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridinesK S Atwal, G C Rovnyak, S D Kimball, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 10, 2003
Oxidative activation of acylguanidine prodrugs: intestinal presystemic activation in rats limits absorption and can be inhibited by co-administration of ketoconazoleW G Humphreys, M T Obermeier, S Chong, et al.
Pageof 3